We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Automated Workflow Offers PCR-Based Molecular Diagnostic Assay Menu

By LabMedica International staff writers
Posted on 01 Sep 2010
A novel, integrated system sets new standards for molecular testing and incorporates all workflow steps from sample to detection.

The system offers features that create flexibility, such as continuous loading, random access, open channels for user-developed tests, and a very broad menu of commercial assays. It has the ability to process an almost unlimited range of sample types and it should transform the laboratory's work in the emerging field of molecular diagnostic

Image: The QIAsymphony RGQ (photo courtesy Qiagen).
Image: The QIAsymphony RGQ (photo courtesy Qiagen).

This new and complete workflow solution is comprised of modules that can be used as standalone systems or combined into a fully integrated system. Called QIAsymphony RGQ, and introduced by Qiagen (Frankfurt, Germany), the system comprises the physical and data integration of the modules QIAsymphony SP for sample preparation, QIAsymphony AS for assay setup, and the Rotor-Gene Q real time polymerase chain reaction (PCR) thermocycler.

QIAsymphony provides the broadest available PCR-based assay menu, including the Artus real time PCR kits for the detection of human immunosuppression virus (HIV), Human hepatitis C and B viruses (HCV, HBV), and a transplantation panel with Cytomegalovirus (CMV), Epstein Bar virus (EBV), Herpes simplex virus (HSV), Varicella-Zoster (VZV) and BK virus (BKV1). (BK was the initials of the patient from whom the virus was first isolated).

A large pipeline of more tests will be launched in the coming months, including TheraScreen, epidermal growth factor receptor (EGFR), KRAS, as well as Artus Influenza, Computed tomography (CT), CT Neisseria gonorrhoeae (CT/Ng) and an extended transplantation panel. Many more tests are in development including integration of detection options such as pyrosequencing and multiplexing solutions.

Qiagen N.V., a Netherlands holding company, is a global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA, and proteins from biological samples such as blood or tissue. Assay technologies are used to make such isolated bio-molecules visible.

Related Links:
Qiagen



Gold Member
Serological Pipets
INTEGRA Serological Pipets
Portable Electronic Pipette
Mini 96
New
Sample Transportation System
Tempus1800 Necto
New
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit

Latest Microbiology News

Microfluidic Platform Assesses Neutrophil Function in Sepsis Patients
01 Sep 2010  |   Microbiology

New Diagnostic Method Confirms Sepsis Infections Earlier
01 Sep 2010  |   Microbiology

New Markers Could Predict Risk of Severe Chlamydia Infection
01 Sep 2010  |   Microbiology